[Certified prostate cancer centers of the German Cancer Society : Current status 2 years after certification and future developments].

Der Urologe. Ausg. A
J A SteffensP Albers

Abstract

The 12-month data for 21 of the 44 certified centers were analyzed 2 years after certification of the first prostate cancer centers of the German Cancer Society. Currently about 25% of patients with prostate cancer are being treated in the centers certified by the German Cancer Society. On the one hand, a positive development toward interdisciplinary management can be observed with verifiably good surgical quality in most of the centers and good outpatient care provided by social services, and in some instances psycho-oncological support. On the other hand, there are substantial problems with data documentation. The quality of documentation declines considerably when the patient leaves the hospital. Concerted efforts must be made to improve documentation of patient data and transfer of aftercare information. The association with hospital cancer registries must be enhanced. The quality of both inpatient care and intersectoral care can only be improved on a long-term basis when the insurance providers support this development. Only when there is evidence for improved treatment quality can the long-term development of centers be justified, but until this is corroborated the establishment of centers cannot remain without financing.

References

Nov 28, 2008·Journal of Structural and Functional Genomics·Konstantin ArnoldTorsten Schwede
Jan 30, 2009·Diabetes, Obesity & Metabolism·W M BrownUNKNOWN Type 1 Diabetes Genetics Consortium
Jan 31, 2009·Journal of Cellular Biochemistry·Richard J MurrillsPeter V N Bodine
Mar 20, 2009·Aktuelle Urologie·C Arsov, P Albers

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.